Navigation Links
QualityMetric Appoints Chief Innovation and Research Officer
Date:1/29/2008

James E. Dewey, PhD, QualityMetric co-founder and board member, health risk appraisal (HRA) pioneer, and successful entrepreneur rejoins the company.

LINCOLN, R.I., Jan. 29 /PRNewswire/ -- QualityMetric today announced the return of James E. Dewey, PhD to the company he helped found in 1997. Dewey, whose new title is Chief Innovation and Research Officer (CIRO), reports directly to John E. Ware, PhD, QualityMetric's Chief Executive Officer and co- founder.

"As CIRO, Jim will lead QualityMetric's team of scientists and direct our product development efforts," says Ware. "We are experiencing an unprecedented level of interest in measuring outcomes from all corners of the healthcare landscape. This heightened demand requires creativity and inspired innovation from our team, and Jim is the person to provide this spark."

According to Dewey, "QualityMetric is an exciting place to be right now. We have assembled an amazing team of talented people including measurement scientists, data analysts, and IT professionals. I look forward to channeling this talent and energy to deliver patient-centered, outcomes-based systems to improve healthcare."

Dewey received his doctorate from Purdue University, conducting landmark research validating the Centers for Disease Control Health Risk Appraisal. While completing his degree, he founded and ran one of the country's first hospital-based Wellness Centers. Dewey's first company, Healthtech Industries, developed custom software applications in health risk appraisal for clients like Mobil Oil Corporation, the United States Navy, and multiple state and local health departments.

Recognizing that many doctors, nurses, and educators found risk appraisal systems complex and frustrating, he formed his second company, Response Technologies, Inc, developing the world's first fully integrated and self-contained system for conducting point-of-care health and health risk assessments.

Dewey and Ware co-founded QualityMetric in 1997, introducing patient-reported outcomes and other health-related Quality of Life measurement tools that Ware and his colleagues pioneered in ground-breaking Population Health studies like the Medical Outcomes Study (MOS) and the Medicare Health Outcomes Survey (MHOS).

About QualityMetric:

QualityMetric is the leading provider of health outcomes measurement surveys and real-time delivery systems that use proprietary methodologies and data assets to produce actionable health information. The company was founded in 1997 by John E. Ware, Jr., PhD, principal developer of the world's most widely used patient-reported outcomes surveys including the SF-36v2(R), SF-12v2(R), SF-10(TM) for Children, and SF-8(TM) Health Surveys. QualityMetric developed the world's first dynamic health assessments(DYNHA(R)), dramatically enhancing the insight that can be derived from outcomes data. Supported by an Outcomes Insight(TM) Analytics Team, QualityMetric clients benefit from full-service solutions that combine scientific integrity, practical generic and disease-specific health information, ease of use and cost efficiency. Visit us at http://www.qualitymetric.com


'/>"/>
SOURCE QualityMetric
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Allos Therapeutics Appoints Bruce K. Bennett as Vice President, Manufacturing
2. Murad, Inc. Appoints Jeff Murad to Vice-President of Product Development
3. ZYTO Corp. Appoints New Chief Operations Officer and New Chief Financial Officer
4. Batesville Holdings, Inc., Appoints Cynthia L. Lucchese Senior Vice President and Chief Financial Officer
5. VNUS Medical Technologies Appoints Peter Osborne as Chief Financial Officer
6. LifeSync Corporation Appoints Nancy McLane as Senior Vice President Operations
7. ChemoCentryx Appoints Edward E. Penhoet, Ph.D., to Board of Directors
8. Cardiva Medical, Inc. Appoints Two New Officers: Malcolm Farnsworth as Vice President of Finance and Chief Financial Officer and Tara Zerby as Vice President of Business Development and Marketing
9. Kendle Appoints Industry Veteran to Lead Asia/Pacific Expansion
10. LifeVantage Corporation Appoints Industry Veteran David Brown as President & CEO
11. Crdentia Appoints Debbie Griffith to Director of Business Development, Reporting Directly to CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... , ... July 24, 2017 , ... ... office at 2307 Bellmore Avenue, Bellmore, New York, (516) 784-5858. The office opened ... M.D. and physician assistants Lori Friedman and Fruma Leah Wiederman. , Advanced ...
(Date:7/24/2017)... ... 24, 2017 , ... “Nana Nana Boo Boo”: a delightful tale of a ... “Nana Nana Boo Boo” is the creation of published author Michael Rush, a Deputy ... Faith Publishing, Michael Rush’s new book presents the importance of manners in a way ...
(Date:7/24/2017)... ... ... “Journey to the Light: The Quest for Happiness and Love. . . through Faith”: ... “Journey to the Light: The Quest for Happiness and Love. . . through ... manuals, and articles, who has recently decided to expand her literary horizons and write ...
(Date:7/23/2017)... Alexandria, Virginia (PRWEB) , ... July 24, 2017 ... ... during the American Association of Physicists in Medicine (AAPM) 59th Annual Meeting & ... , Members of the medical physics profession, hospital administrators and journalists can visit ...
(Date:7/23/2017)... ... July 23, 2017 , ... A 20-year-long study by a national ... the Minneapolis Veterans Administration Health Care System overwhelmingly supports growing evidence that prostate cancer ... benefits. , In the cases involved with this study, surgery did not prolong ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... 10, 2017  The tenth annual BioPharm America™ ... at the Sheraton Boston Hotel, September 26–27. ... to global decision makers and innovative biotech startup companies. ... leaders during two impactful days. BioPharm America is now ... additional networking opportunities with 4,500+ life science industry influencers ...
(Date:7/5/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... ), a clinical-stage pharmaceutical company focused on the development of ... approval from the Israel Securities Authority to dual-list its common ... stock will commence trading on the TASE on July 12, ... capitalization of the Company, it is expected that Oramed will ...
(Date:6/30/2017)... ROCKVILLE, Md. , June 30, 2017 ... that since the start of May, at least ten ... financings include private investments, public offerings and a loan ... $3.3 million to almost $80 million.  Kalorama Information provides ... customers of its Diagnostics Knowledge Center. ...
Breaking Medicine Technology: